This article was originally published on ETFTrends.com.
By Joshua Rodriguez via Iris.xyz As we near the halfway point in the year, investors are starting to look for opportunities to capitalize on in the second half. Biotechnology stocks can generate strong opportunities, as they are riddled with catalytic events through the development, regulatory and commercial processes. While a tech or services company may [...]
Continue Reading Below